Emmanuel U. Emeasoba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emmanuel U. Emeasoba has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Ari Holtzman
Department of Surgery, Albert Einstein College of Medicine, Bronx 10461, NY, USA
1 shared publication- Azka Naeem
Division of Cardiovascular Imaging (A.N., R.P., O.K.K.), St. Francis Hospital and Heart Center, Roslyn, NY
1 shared publication - Colin P. Dunn
Esophageal Institute, Allegheny Health Network, Pittsburgh, PA, USA
1 shared publication - Divya Situt
School of Medicine, St. George’s University Grenada, True Blue, West Indies, Grenada
1 shared publication - Eran Bellin
Departments of Epidemiology & Population Health and Medicine Albert Einstein College of Medicine Bronx New York USA
1 shared publication - Jacob Shani
Maimonides Medical Center, Brooklyn, USA
1 shared publication
Latest Publications
- Open Access
- 9 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (4) , 1100
Understanding the Intricacies of Khat-Associated Cardiovascular Disease
Khat, derived from the Catha edulis plant, is widely consumed in East Africa and the Arabian Peninsula, where it holds significant socio-cultural importance. This review examines the multifaceted effects of khat, particularly focusing on its cardiovascular implications. Khat’s active constituents, notably cathinone and cathine, exhibit stimulant and psychoactive properties akin to amphetamines, leading to heightened alertness and euphoria. However, chronic consumption is associated with adverse effects, including cardiovascular diseases such as hypertension, myocardial infarction, and cardiomyopathy. The review highlights the pharmacokinetics of khat, with cathinone being rapidly absorbed and leading to sympathomimetic effects. Studies indicate a correlation between chronic khat use and increased risks of hypertension, acute coronary syndromes, and cardiomyopathy. These cardiovascular conditions are exacerbated by prolonged hemodynamic stress, catecholamine release, and oxidative stress induced by khat’s active compounds. Additionally, khat’s impact extends beyond the cardiovascular system, affecting neurological, reproductive, and gastrointestinal health. Despite its legality in certain regions, khat is classified as a controlled substance in many countries, emphasizing the need for global awareness of its health risks. This review calls for longitudinal studies to elucidate the pathophysiological mechanisms of khat-induced cardiomyopathy and to identify potential biomarkers for its early detection. Furthermore, it advocates for culturally sensitive public health initiatives and clinical guidelines to mitigate the adverse health effects of khat consumption, especially among immigrant populations in developed nations. Recognizing and addressing khat’s cardiovascular implications is crucial for improving patient outcomes and guiding effective clinical practice.
- 9 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (4) , 1100
Open AccessUnderstanding the Intricacies of Khat-Associated Cardiovascular Disease
Khat, derived from the Catha edulis plant, is widely consumed in East Africa and the Arabian Peninsula, where it holds significant socio-cultural importance. This review examines the multifaceted effects of khat, particularly focusing on its cardiovascular implications. Khat’s active constituents, notably cathinone and cathine, exhibit stimulant and psychoactive properties akin to amphetamines, leading to heightened alertness and euphoria. However, chronic consumption is associated with adverse effects, including cardiovascular diseases such as hypertension, myocardial infarction, and cardiomyopathy. The review highlights the pharmacokinetics of khat, with cathinone being rapidly absorbed and leading to sympathomimetic effects. Studies indicate a correlation between chronic khat use and increased risks of hypertension, acute coronary syndromes, and cardiomyopathy. These cardiovascular conditions are exacerbated by prolonged hemodynamic stress, catecholamine release, and oxidative stress induced by khat’s active compounds. Additionally, khat’s impact extends beyond the cardiovascular system, affecting neurological, reproductive, and gastrointestinal health. Despite its legality in certain regions, khat is classified as a controlled substance in many countries, emphasizing the need for global awareness of its health risks. This review calls for longitudinal studies to elucidate the pathophysiological mechanisms of khat-induced cardiomyopathy and to identify potential biomarkers for its early detection. Furthermore, it advocates for culturally sensitive public health initiatives and clinical guidelines to mitigate the adverse health effects of khat consumption, especially among immigrant populations in developed nations. Recognizing and addressing khat’s cardiovascular implications is crucial for improving patient outcomes and guiding effective clinical practice.
- Open Access
- 25 December 2018
- Published by Wiley in Surgery Research and Practice
- Vol. 2018, 1-8
A Retrospective Cohort Study on Rehospitalization following Expanded Criteria Donor Kidney Transplantation
Background. Expanded criteria donor (ECD) kidneys are commonly used but are associated with increased graft failure. Graft failure is in turn related to rehospitalization within thirty days post transplant. Our goal was to determine whether ECD kidneys independently lead to rehospitalization within 30 days, 1 year, and 2 years after transplant.Methods. All adult first-time recipients of deceased donor kidneys transplanted from 2003–2012 at our center were reviewed. Models included demographics, medical comorbidities, center for disease control high-risk kidney, ECD kidney, ischemia times, cause of renal failure, immunosuppressive regimen, positive psychiatric screening, alcoholism, surgeon, year the transplant was performed, years on dialysis before transplant, and the number of inpatient hospitalizations within 6 months prior to transplant. We conducted Andersen–Gill modeling and propensity score matching followed by logistic regression. We also used multivariable linear regression to predict average length of stay during rehospitalization.Results. More ECD patients had a rehospitalization at 1 year (70.3% versus 59%, log-rank test). Thirty-day and 2-year time marks were not significant. Andersen–Gill models predicting successive hospitalizations yielded HR of 1.42 () and 1.32 () for ECD patients at 1 and 2 years of after transplantation, respectively. Propensity score matching and logistic regression showed a significant relative risk of 1.630 at one year () and 1.313 at two years (). There was no significant association between ECD and subsequent lengths of hospital stay.Conclusion. Receiving an ECD kidney is independently associated with multiple readmissions within 2 years of transplant but unrelated to length of stay.- 25 December 2018
- Published by Wiley in Surgery Research and Practice
- Vol. 2018, 1-8
Open AccessA Retrospective Cohort Study on Rehospitalization following Expanded Criteria Donor Kidney Transplantation
Background. Expanded criteria donor (ECD) kidneys are commonly used but are associated with increased graft failure. Graft failure is in turn related to rehospitalization within thirty days post transplant. Our goal was to determine whether ECD kidneys independently lead to rehospitalization within 30 days, 1 year, and 2 years after transplant.Methods. All adult first-time recipients of deceased donor kidneys transplanted from 2003–2012 at our center were reviewed. Models included demographics, medical comorbidities, center for disease control high-risk kidney, ECD kidney, ischemia times, cause of renal failure, immunosuppressive regimen, positive psychiatric screening, alcoholism, surgeon, year the transplant was performed, years on dialysis before transplant, and the number of inpatient hospitalizations within 6 months prior to transplant. We conducted Andersen–Gill modeling and propensity score matching followed by logistic regression. We also used multivariable linear regression to predict average length of stay during rehospitalization.Results. More ECD patients had a rehospitalization at 1 year (70.3% versus 59%, log-rank test). Thirty-day and 2-year time marks were not significant. Andersen–Gill models predicting successive hospitalizations yielded HR of 1.42 () and 1.32 () for ECD patients at 1 and 2 years of after transplantation, respectively. Propensity score matching and logistic regression showed a significant relative risk of 1.630 at one year () and 1.313 at two years (). There was no significant association between ECD and subsequent lengths of hospital stay.Conclusion. Receiving an ECD kidney is independently associated with multiple readmissions within 2 years of transplant but unrelated to length of stay.